According to the results of transcriptome sequencing, the differentially expressed genes involved in this signaling pathway included CPT1A, CD36, SLC27A4, APOC3, FABP1, and AFN was able to affect the expression of CPT1A, ACADVL, and ACAA2 genes in the fatty acid degradation pathway after intervention in the hyperlipidemia model mice, and the fatty acid degradation pathway (Figure S3). The gene discussed is APOC3; the disease is hyperlipidemia.